Barclays’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$532K Sell
15,980
-219,892
-93% -$7.38M ﹤0.01% 3160
2025
Q4
$8.15M Sell
235,872
-14,509
-6% -$463K ﹤0.01% 1841
2025
Q3
$6.81M Sell
250,381
-70,785
-22% -$1.71M ﹤0.01% 1973
2025
Q2
$6.75M Buy
321,166
+135,800
+73% +$2.61M ﹤0.01% 1861
2025
Q1
$3.04M Sell
185,366
-13,390
-7% -$285K ﹤0.01% 2313
2024
Q4
$5.11M Buy
198,756
+17,586
+10% +$498K ﹤0.01% 2150
2024
Q3
$5.74M Buy
181,170
+118,438
+189% +$4.49M ﹤0.01% 1972
2024
Q2
$2.2M Sell
62,732
-7,234
-10% -$286K ﹤0.01% 2065
2024
Q1
$3.07M Sell
69,966
-106,474
-60% -$4.58M ﹤0.01% 2211
2023
Q4
$6.28M Buy
176,440
+90,114
+104% +$2.69M ﹤0.01% 1906
2023
Q3
$2.33M Buy
86,326
+13,049
+18% +$331K ﹤0.01% 1796
2023
Q2
$1.72M Buy
73,277
+11,020
+18% +$227K ﹤0.01% 1974
2023
Q1
$855K Sell
62,257
-32,086
-34% -$535K ﹤0.01% 2856
2022
Q4
$1.71M Buy
94,343
+23,735
+34% +$399K ﹤0.01% 2368
2022
Q3
$1.05M Buy
70,608
+68,244
+2,887% +$886K ﹤0.01% 2190
2022
Q2
$33K Sell
2,364
-3,078
-57% -$34.2K ﹤0.01% 4205
2022
Q1
$61K Sell
5,442
-34,318
-86% -$506K ﹤0.01% 4033
2021
Q4
$940K Buy
39,760
+26,173
+193% +$608K ﹤0.01% 2872
2021
Q3
$347K Buy
13,587
+1,540
+13% +$36K ﹤0.01% 3362
2021
Q2
$252K Sell
12,047
-2,809
-19% -$57.7K ﹤0.01% 3440
2021
Q1
$348K Buy
14,856
+9,616
+184% +$186K ﹤0.01% 3410
2020
Q4
$73K Sell
5,240
-2,036
-28% -$27.6K ﹤0.01% 4256
2020
Q3
$91K Buy
7,276
+648
+10% +$8.03K ﹤0.01% 4307
2020
Q2
$94K Buy
+6,628
New +$52.2K ﹤0.01% 4561

Other funds holding IDYA